Action enhances microbiology testing services and North American presence.

bioMérieux acquired PML Microbiologicals, a North American provider of culture media and microbiological products for both clinical and industrial applications. The firm was acquired from the Pelican Life Sciences Group for $29.6 million. 

PML has an extensive range of products for use in the clinical and pharmaceutical industries, according to the companies. It specializes in reagents, including prepared culture media (PPM) for sterility testing and environmental monitoring, as well as control organisms, which are complementary to bioMérieux’s offering. PML reported sales of $24 million in 2007.

The acquisition will enhance bioMérieux’ microbiology testing offerings and provide an entrance to the North American clinical PPM market. “This new acquisition, our sixth in two years, reinforces the North American market position of bioMérieux’s core business, microbiology,” declared Stéphane Bancel, CEO of bioMérieux.

PML’s sites in Portland, Oregon, and Toronto will join bioMérieux’ network of culture media production centers with its main site in Craponne (France) and regional facilities in Lombard, Illinois, Madrid, Basingstoke (England), Brisbane (Australia), and Rio de Janeiro.

Previous articleResearch Leads to Further Understanding of Nucleolar Dominance
Next articleProfectus BioSciences Awarded $21.6M from NIAID to Develop HIV Vaccines